|
Volumn 23, Issue 33, 2005, Pages 8543-8544
|
Computer modeling is no substitute for randomized clinical trials for decision making in early breast cancer hormonal therapy [7]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AROMATASE INHIBITOR;
TAMOXIFEN;
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
BREAST CANCER;
CANCER RECURRENCE;
CANCER SURVIVAL;
CLINICAL TRIAL;
COMPUTER MODEL;
CONTROLLED CLINICAL TRIAL;
HORMONAL THERAPY;
HUMAN;
LETTER;
MEDICAL DECISION MAKING;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SENSITIVITY ANALYSIS;
BREAST TUMOR;
COMPUTER SIMULATION;
DECISION SUPPORT SYSTEM;
FEMALE;
NOTE;
ANTINEOPLASTIC AGENTS, HORMONAL;
BREAST NEOPLASMS;
COMPUTER SIMULATION;
DECISION SUPPORT TECHNIQUES;
FEMALE;
HUMANS;
RANDOMIZED CONTROLLED TRIALS;
|
EID: 33644670156
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2005.03.7374 Document Type: Letter |
Times cited : (2)
|
References (5)
|